Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00116129|
Recruitment Status : Completed
First Posted : June 28, 2005
Last Update Posted : August 6, 2012
Bennett, Robert, M.D.
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Robert Bennett MD, Bennett, Robert, M.D.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||January 2008|
|Actual Study Completion Date :||April 2008|
Bennett RM, Cook DM, Clark SR, Burckhardt CS, Campbell SM. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol. 1997 Jul;24(7):1384-9.